Patient outcomes are better indicator than patient volume for selecting hospitals for VLBW babies

January 13, 2004

Using a direct quality indicator, such as a survival rate, may be more effective than using an indirect quality indicator, such as patient volume, when selecting hospitals for care of a very low birth weight infant, according to a study in the January 14 issue of The Journal of the American Medical Association (JAMA).

According to background information in the article, evidence-based selective referral strategies are being used by an increasing number of insurers to ensure that medical care is provided by high-quality providers and to make sure that patients with high-risk conditions are treated in hospitals with the best outcomes. In the absence of direct-quality measures based on patient outcomes, the standards currently in place for many conditions rely on indirect-quality measures such as patient volume.

Jeannette A. Rogowski, Ph.D., of RAND, Arlington, Va., and colleagues assessed the potential usefulness of indirect-quality indicators such as patient volume for very low birth weight (VLBW) infants and compared indirect-quality indicators with direct measures, such as survival rate at a hospital.

The study included 94,110 VLBW infants weighing 501 to 1500 grams (17.7 to 53 ounces) born in 332 Vermont Oxford Network hospitals with neonatal intensive care units (NICU) between January 1, 1995, and December 31, 2000.

The researchers found that in hospitals with less than 50 annual admissions of VLBW infants, an additional 10 admissions were associated with an 11 percent reduction in mortality. "The annual volume of admissions only explained 9 percent of the variation across hospitals in mortality rates, and other readily available hospital characteristics explained an additional 7 percent. Historical volume was not significantly related to mortality rates in 1999-2000, implying that volume cannot prospectively identify high-quality providers," the authors write.

In contrast, hospitals in the lowest mortality quintile between 1995 and 1998 were found to have significantly lower mortality rates in 1999-2000 and hospitals in the highest mortality quintile between 1995 and 1998 had significantly higher mortality rates in 1999-2000. "The percentage of hospital-level variation in mortality in 1999-2000 that was forecasted by the highest and lowest quintiles based on patient mortality was 34 percent compared with only 1 percent for the highest and lowest quintiles of volume," the researchers add.

"These results suggest that the current ... standard, which is based on only volume and level of care at the NICU, would tend to be an unreliable indicator of quality in our sample of hospitals (e.g., many hospitals with low-patient volume or low-level NICUs would have better patient outcomes and vice versa).

"Our results suggest that direct-quality indicators based on patient mortality are likely to outperform indirect-quality indicators such as patient volume and more lives could potentially be saved if patient referrals were based on the former rather than the latter. The difference in mortality between the best and worst hospitals was more than 5 times larger when ranking hospitals on past-mortality rates compared with ranking hospitals on past volume. Thus, moving patients out of hospitals with high past mortality and into hospitals with lower past mortality will have a larger impact than moving patients from low-volume to high-volume hospitals," they write. (JAMA. 2004;291:202-209. Available post-embargo at http://www.JAMA.com)
-end-
Editor's Note: This study was supported by grants from the Agency for Healthcare Research and Quality. Dr. Rogowski is a member of the Vermont Oxford Network Database Advisory Committee. Co-author Dr. Horbar is chief executive and scientific officer for the Vermont Oxford Network. Co-author Mr. Carpenter is an employee of the Vermont Oxford Network.

The JAMA Network Journals

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.